All In Biotech

Drug Trial Radar · NCT02853552

Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding

Use of Misoprostol by Families and Women as a First Aid Measure to Address Excessive Postpartum Bleeding in Home Deliveries

Last checked: Nov 20, 2026Latest source record: Aug 3, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

4,330

Planned (sponsor's estimate)

Start

Oct 2016

Primary completion

Oct 2017

Study completion Oct 2017

Sponsor

Lead sponsor
Gynuity Health ProjectsAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Committee for Maternal & Neonatal Health
First posted
Aug 3, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Health services research
Who can join
Female only
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The overall study purpose is to evaluate the safety, feasibility and acceptability of advance distribution of misoprostol to be used as 'first aid treatment' administered by the woman herself or her family to help treat excessive bleeding in home births.

Conditions

  • Postpartum Hemorrhage

Interventions

  • MisoprostolDrug

    800mcg misoprostol taken sublingually

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of cases identified as having excessive bleedingTime frame: Within 1 week after delivery
  2. Proportion of women who administer misoprostol as first aidTime frame: Within 1 week after delivery
  3. Proportion of women who correctly administer misoprostol as first aidTime frame: Within 1 week after delivery
  4. Acceptability of side effects of misoprostolTime frame: Within 1 week after delivery
  5. Number of women who are transferred for excessive bleedingTime frame: Within 1 week after delivery
  6. Proportion of women who experience a serious adverse event due to excessive bleedingTime frame: Within 1 week after delivery
  7. Proportion of women who receive an additional intervention (e.g. use of additional uterotonic or suturing) for excessive bleedingTime frame: Within 1 week after delivery
  8. Level of acceptability and satisfaction with using misoprostol as first-aid option to treat excessive bleedingTime frame: Within 1 week after delivery
  9. Correct comprehension of information related to misoprostol and its use for first aidTime frame: Within 1 week after delivery

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.